WisdomTree grants 9,554 PRSUs to Europe CEO

Marinof Alexis reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Marinof Alexis reported acquisition or exercise transactions in this Form 4 filing.

WisdomTree, Inc. filed an amended Form 4 showing that Alexis Marinof, CEO Europe, received a grant of 9,554 performance-based restricted stock units (PRSUs). Each PRSU represents the right to receive one share of common stock upon vesting.

The PRSUs are scheduled to vest on January 25, 2029, with the actual shares issued ranging from 0% to 200% of the 9,554 target units based on performance. The amendment updates the target number of PRSUs to align with the grant date fair market value determined by an independent valuation consultant.

Insider Trade Summary

Grant/Award: 9,554 shares

Grant/Award 1 txn

Insider Marinof Alexis

Role CEO, Europe

Type	Security	Shares	Price	Value
Grant/Award	Performance Based Restricted Stock Units	9,554	$0.00	$0.00

Holdings After Transaction: Performance Based Restricted Stock Units — 9,554 contracts (Direct)

Footnotes (2)

1. F1. Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.
2. F2. These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did WisdomTree (WT) report in this Form 4/A?

WisdomTree reported an amended grant of performance-based restricted stock units to its Europe CEO. The filing shows 9,554 PRSUs awarded, each representing the right to receive one share of common stock if vesting and performance conditions are satisfied over time.

How many performance-based restricted stock units did WisdomTree (WT) grant to Alexis Marinof?

The company granted 9,554 performance-based restricted stock units to Alexis Marinof. Each PRSU can convert into one share of common stock at vesting, subject to achievement of defined performance conditions that may increase or reduce the number of shares ultimately delivered.

When do the WisdomTree (WT) PRSUs granted to the Europe CEO vest?

The performance-based restricted stock units are scheduled to vest on January 25, 2029. Actual vesting will depend on satisfying performance criteria, and the number of common shares issued can range from 0% to 200% of the 9,554 target PRSUs noted in the filing.

What performance range applies to the WisdomTree (WT) PRSU grant in this Form 4/A?

The PRSU payout can range from 0% to 200% of the 9,554 target units. That means the executive could receive no shares if goals are missed or up to double the target amount if predefined performance objectives are fully achieved during the measurement period.

Why did WisdomTree (WT) file this as an amended Form 4/A?

The amendment updates the target number of PRSUs to match the grant date fair market value. An independent valuation consultant determined this value, and the filing clarifies the adjusted target PRSU amount while preserving the original performance-based and vesting terms.

Who is the reporting person in WisdomTree (WT) Form 4/A and what role do they hold?

The reporting person is Alexis Marinof, who serves as WisdomTree’s CEO, Europe. The filing reflects an equity incentive grant directly to him, structured as performance-based restricted stock units that may convert into common shares depending on future performance and vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:41 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marinof Alexis

(Last) (First) (Middle)

250 WEST 34TH STREET, 3RD FLOOR

C/O WISDOMTREE, INC.

(Street)

NEW YORK NY 10119

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WisdomTree, Inc. [ WT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Europe

3. Date of Earliest Transaction (Month/Day/Year)
01/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
01/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Based Restricted Stock Units	(1)	01/25/2026		A		9,554		(2)	(2)	Common Stock	9,554	$0.0000	9,554	D

Explanation of Responses:

1. Each performance-based restricted stock unit represents the right to receive, on the vesting date, one share of common stock for each such unit that vests.

2. These PRSUs are scheduled to vest on January 25, 2029. The number of shares of Common Stock to be issued will range between 0% and 200% of the target number of PRSUs indicated above. This Amendment to Form 4 is being filed to update the target number of PRSUs to reflect the grant date fair market value of the PRSUs as determined by an independent valuation consultant.

	/s/ Marci Frankenthaler, Attorney-in-Fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.